PubMed:23275522 / 109-172 JSONTXT

{"project":"sentences","denotations":[{"id":"T2","span":{"begin":0,"end":63},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Aberrant glycosylation is a common feature of malignant change."}

{"project":"sentences","denotations":[{"id":"T2","span":{"begin":0,"end":63},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Aberrant glycosylation is a common feature of malignant change."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T2","span":{"begin":0,"end":63},"obj":"Sentence"}],"text":"Aberrant glycosylation is a common feature of malignant change."}

{"project":"Lectin-Jamboree-Sentence","blocks":[{"id":"T2","span":{"begin":0,"end":63},"obj":"Sentence"}],"text":"Aberrant glycosylation is a common feature of malignant change."}